NcRNA-microchip analysis: A novel approach to identify differential expression of non-coding RNAs

RNA Biology

Volumn 7, Issue 5, 2010, Pages 586-595

  Hutzinger, Roland ^a   Mrázek, Jan ^a,b   Vorwerk, Sonja ^c   Hüttenhofer, Alexander ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Febit Biomed GmbH   (Germany)

Author keywords

Alu; Deep sequencing; EBV; Microchip; ncRNA; Viral

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; RIBONUCLEASE P; RIBOZYME; TRANSFER RNA; UNTRANSLATED RNA;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DNA DETERMINATION; DNA LIBRARY; DNA SEQUENCE; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MICROCHIP ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; RNA ANALYSIS; VIRUS CARCINOGENESIS;

HUMAN HERPESVIRUS 4;

EID: 78649360168     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.7.5.12971     Document Type: Article

References (42)

1. Murray PG, Young LS. Epstein-Barr virus infection: basis of malignancy and potential for therapy. Expert Rev Mol Med 2001; 3:1-20.
2. Rickinson ABKE. Epstein-Barr Virus. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, et al. Fields Virology: Lippincott Williams & Wilkins Publishers 2007; 2655-700.
3. Kutok JL, Wang F. Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 2006; 1:375-404.
4. Lerner MR, Andrews NC, Miller G, Steitz JA. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1981; 78:805-9.
5. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, et al. Identification of virus-encoded microRNAs. Science 2004; 304:734-6.
6. Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, Grasser F, et al. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 2009; 83:3333-41.
7. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, et al. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2006; 2:23.
8. Hutzinger R, Feederle R, Mrazek J, Schiefermeier N, Balwierz PJ, Zavolan M, et al. Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome. PLoS Pathog 2009; 5:1000547.
9. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J 2002; 21:954-65.
10. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, Kremmer E, et al. Epstein-Barr virus-encoded microRNA miR-BART2 downregulates the viral DNA polymerase BALF5. Nucleic Acids Res 2008; 36:666-75.
11. Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, Sapucaia JB, et al. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 2008; 68:1436-42.
12. Lo AK, To KF, Lo KW, Lung RW, Hui JW, Liao G, et al. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci USA 2007; 104:16164-9.
13. Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, To KF, et al. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exper Med 2008; 205:2551-60.
14. Mrazek J, Kreutmayer SB, Grasser FA, Polacek N, Huttenhofer A. Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res 2007; 35:73.
15. Kiss C, Nishikawa J, Dieckmann A, Takada K, Klein G, Szekely L. Improved subtractive suppression hybridization combined with high density cDNA array screening identifies differentially expressed viral and cellular genes. J Virol Methods 2003; 107:195-203.
16. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34:140-4.
17. Lestrade L, Weber MJ. snoRNA-LBME-db, a comprehensive database of human H/ACA and C/D box snoRNAs. Nucleic Acids Res 2006; 34:158-62.
18. Shingara J, Keiger K, Shelton J, Laosinchai-Wolf W, Powers P, Conrad R, et al. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 2005; 11:1461-70.
19. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004; 101:11755-60.
20. Baum M, Bielau S, Rittner N, Schmid K, Eggelbusch K, Dahms M, et al. Validation of a novel, fully integrated and flexible microarray benchtop facility for gene expression profiling. Nucleic Acids Res 2003; 31:151.
21. Vorwerk S, Ganter K, Cheng Y, Hoheisel J, Stahler PF, Beier M. Microfluidic-based enzymatic on-chip labeling of miRNAs. New Biotechnol 2008; 25:142-9.
22. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, et al. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 2002; 99:16899-903.
23. Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res 2008; 36:70-4.
24. Kazazian HH Jr. Mobile elements: drivers of genome evolution. Science 2004; 303:1626-32.
25. Batzer MA, Deininger PL. Alu repeats and human genomic diversity. Nat Rev 2002; 3:370-9.
26. Mills RE, Bennett EA, Iskow RC, Devine SE. Which transposable elements are active in the human genome? Trends Genet 2007; 23:183-91.
27. Li TH, Schmid CW. Differential stress induction of individual Alu loci: implications for transcription and retrotransposition. Gene 2001; 276:135-41.
28. Mariner PD, Walters RD, Espinoza CA, Drullinger LF, Wagner SD, Kugel JF, et al. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol Cell 2008; 29:499-509.
29. Cameron JE, Fewell C, Yin Q, McBride J, Wang X, Lin Z, et al. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 2008; 382:257-66.
30. Sredni ST, Bonaldo MD, Costa FF, Huang CC, Hamm CA, Rajaram V, et al. Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets. Childs Nerv Syst 2010; 26:279-83
31. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafre SA, et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007; 282:23716-24.
32. Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg 2009; 33:698-709.
33. Kiss T. Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell 2002; 109:145-8.
34. Nandy C, Mrazek J, Stoiber H, Grasser FA, Huttenhofer A, Polacek N. Epstein-barr virus-induced expression of a novel human vault RNA. J Mol Biol 2009; 388:776-84.
35. Pace NR, Brown JW. Evolutionary perspective on the structure and function of ribonuclease P, a ribozyme. J Bacteriol 1995; 177:1919-28.
36. Jochl C, Rederstorff M, Hertel J, Stadler PF, Hofacker IL, Schrettl M, et al. Small ncRNA transcriptome analysis from Aspergillus fumigatus suggests a novel mechanism for regulation of protein synthesis. Nucleic Acids Res 2008; 36:2677-89.
37. Panning B, Smiley JR. Activation of expression of multiple subfamilies of human Alu elements by adenovirus type 5 and herpes simplex virus type 1. J Mol Biol 1995; 248:513-24.
38. Yeung ML, Bennasser Y, Jeang KT. miRNAs in the biology of cancers and viral infections. Curr Med Chem 2007; 14:191-7.
39. Kip1. J Biol Chem 2008; 283:29897-903.
40. Pattengale PK, Smith RW, Gerber P. Selective transformation of B lymphocytes by E.B. virus. Lancet 1973; 2:93-4.
41. Miller G, Shope T, Lisco H, Stitt D, Lipman M. Epstein-Barr virus: transformation, cytopathic changes and viral antigens in squirrel monkey and marmoset leukocytes. Proc Nat Acad Sci USA 1972; 69:383-7.
42. Kohany O, Gentles AJ, Hankus L, Jurka J. Annotation, submission and screening of repetitive elements in Repbase: RepbaseSubmitter and Censor. BMC Bioinformatics 2006; 7:474.